-
1
-
-
68249096673
-
Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study)
-
Baeza I, Graell M, Moreno D, Castro-Fornieles J, Parellada M, González-Pinto A, Payá B, Soutullo C, de la Serna E, Arango C. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009;113:129-37.
-
(2009)
Schizophr Res.
, vol.113
, pp. 129-137
-
-
Baeza, I.1
Graell, M.2
Moreno, D.3
Castro-Fornieles, J.4
Parellada, M.5
González-Pinto, A.6
Payá, B.7
Soutullo, C.8
Serna, E.9
Arango, C.10
-
2
-
-
84863878430
-
Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis
-
Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry. 2012;27:463-9.
-
(2012)
Eur Psychiatry.
, vol.27
, pp. 463-469
-
-
Schimmelmann, B.G.1
Conus, P.2
Cotton, S.3
Kupferschmid, S.4
McGorry, P.D.5
Lambert, M.6
-
4
-
-
84900350562
-
Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study
-
Donoghue K, Doody GA, Murray RM, Jones PB, Morgan C, Dazzan P, et al. Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study. Psychiatry Res. 2014;215:528-32.
-
(2014)
Psychiatry Res.
, vol.215
, pp. 528-532
-
-
Donoghue, K.1
Doody, G.A.2
Murray, R.M.3
Jones, P.B.4
Morgan, C.5
Dazzan, P.6
-
5
-
-
84874830696
-
Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis
-
van der Meer FJ, Velthorst E, Meijer CJ, Machielsen MWJ, de Haan L. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis. Curr Pharm Des. 2012;18:5036-44.
-
(2012)
Curr Pharm Des.
, vol.18
, pp. 5036-5044
-
-
Meer, F.J.1
Velthorst, E.2
Meijer, C.J.3
Machielsen, M.W.J.4
Haan, L.5
-
6
-
-
49649121541
-
Impact of cannabis and other drugs on age at onset psychosis
-
González-Pinto A, Vega P, Ibañez B, Mosquera F, Barbeito S, Gutierrez M, et al. Impact of cannabis and other drugs on age at onset psychosis. J Clin Psychiatry. 2008;69:1210-16.
-
(2008)
J Clin Psychiatry.
, vol.69
, pp. 1210-1216
-
-
González-Pinto, A.1
Vega, P.2
Ibañez, B.3
Mosquera, F.4
Barbeito, S.5
Gutierrez, M.6
-
7
-
-
84891811498
-
Cannabis use and first episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation
-
Stone JM, Fisher HL, Major B, Chisholm B, Woolley J, Lawrence J, et al. Cannabis use and first episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med. 2014;44:499-506.
-
(2014)
Psychol Med.
, vol.44
, pp. 499-506
-
-
Stone, J.M.1
Fisher, H.L.2
Major, B.3
Chisholm, B.4
Woolley, J.5
Lawrence, J.6
-
8
-
-
84874400244
-
The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS)
-
Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi K, PICOS-VENETO GROUP, et al. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J Psychiatric Res. 2013;47:438-44.
-
(2013)
J Psychiatric Res.
, vol.47
, pp. 438-444
-
-
Tosato, S.1
Lasalvia, A.2
Bonetto, C.3
Mazzoncini, R.4
Cristofalo, D.5
Santi, K.6
-
9
-
-
79956120635
-
Cannabis use and earlier onset of psychosis: a systematic meta-analysis
-
Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68:555-61.
-
(2011)
Arch Gen Psychiatry.
, vol.68
, pp. 555-561
-
-
Large, M.1
Sharma, S.2
Compton, M.T.3
Slade, T.4
Nielssen, O.5
-
10
-
-
77950453195
-
Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis
-
Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, et al. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010;55:165-71.
-
(2010)
Can J Psychiatry.
, vol.55
, pp. 165-171
-
-
Dragt, S.1
Nieman, D.H.2
Becker, H.E.3
Fliert, R.4
Dingemans, P.M.5
Haan, L.6
-
11
-
-
83555176239
-
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
-
Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, EPOS group, et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand. 2012;125:45-53.
-
(2012)
Acta Psychiatr Scand.
, vol.125
, pp. 45-53
-
-
Dragt, S.1
Nieman, D.H.2
Schultze-Lutter, F.3
Meer, F.4
Becker, H.5
Haan, L.6
-
12
-
-
84895814739
-
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users
-
Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo SA, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2014;40:1509-17.
-
(2014)
Schizophr Bull.
, vol.40
, pp. 1509-1517
-
-
Forti, M.1
Sallis, H.2
Allegri, F.3
Trotta, A.4
Ferraro, L.5
Stilo, S.A.6
-
13
-
-
34447106643
-
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use
-
Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, et al. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res. 2007;94:29-36.
-
(2007)
Schizophr Res.
, vol.94
, pp. 29-36
-
-
Leweke, F.M.1
Giuffrida, A.2
Koethe, D.3
Schreiber, D.4
Nolden, B.M.5
Kranaster, L.6
-
14
-
-
39149145495
-
Cannabis use and brain structural alterations in first episode schizophrenia-a region of interest, voxel based morphometric study
-
Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS. Cannabis use and brain structural alterations in first episode schizophrenia-a region of interest, voxel based morphometric study. Schizophr Res. 2008;99:1-6.
-
(2008)
Schizophr Res.
, vol.99
, pp. 1-6
-
-
Bangalore, S.S.1
Prasad, K.M.2
Montrose, D.M.3
Goradia, D.D.4
Diwadkar, V.A.5
Keshavan, M.S.6
-
15
-
-
79955473886
-
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
-
Ho BC, Wassink TH, Ziebell S, Andreasen NC. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res. 2011;128:66-75.
-
(2011)
Schizophr Res.
, vol.128
, pp. 66-75
-
-
Ho, B.C.1
Wassink, T.H.2
Ziebell, S.3
Andreasen, N.C.4
-
16
-
-
79951511304
-
Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation
-
Zoppi S, Perez- Nievas BG, Madrigal JL, Manzanares J, Leza JC, García-Bueno B. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology. 2011;36:805-18.
-
(2011)
Neuropsychopharmacology
, vol.36
, pp. 805-818
-
-
Zoppi, S.1
Perez-Nievas, B.G.2
Madrigal, J.L.3
Manzanares, J.4
Leza, J.C.5
García-Bueno, B.6
-
17
-
-
46849111394
-
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia
-
Eggan SM, Hashimoto T, Lewis DA. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry. 2008;65:772-84.
-
(2008)
Arch Gen Psychiatry.
, vol.65
, pp. 772-784
-
-
Eggan, S.M.1
Hashimoto, T.2
Lewis, D.A.3
-
18
-
-
77951620284
-
Brain cannabinoid CB2 receptor in schizophrenia
-
Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, et al. Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry. 2010;67:974-82.
-
(2010)
Biol Psychiatry.
, vol.67
, pp. 974-982
-
-
Ishiguro, H.1
Horiuchi, Y.2
Ishikawa, M.3
Koga, M.4
Imai, K.5
Suzuki, Y.6
-
19
-
-
2942520782
-
Endocannabinoid signalling in the blood of patients with schizophrenia
-
De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis. 2003;2:5.
-
(2003)
Lipids Health Dis.
, vol.2
, pp. 5
-
-
Marchi, N.1
Petrocellis, L.2
Orlando, P.3
Daniele, F.4
Fezza, F.5
Marzo, V.6
-
20
-
-
8444242207
-
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
-
Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology. 2004;29:2108-14.
-
(2004)
Neuropsychopharmacology.
, vol.29
, pp. 2108-2114
-
-
Giuffrida, A.1
Leweke, F.M.2
Gerth, C.W.3
Schreiber, D.4
Koethe, D.5
Faulhaber, J.6
-
21
-
-
79955442545
-
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use
-
González-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibáñez B, et al. Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull. 2011;37:631-39.
-
(2011)
Schizophr Bull.
, vol.37
, pp. 631-639
-
-
González-Pinto, A.1
Alberich, S.2
Barbeito, S.3
Gutierrez, M.4
Vega, P.5
Ibáñez, B.6
-
22
-
-
84889854747
-
Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
-
Clausen L, Hjorthoj CR, Thorup A, Jeppesen P, Petersen L, Bertelsen M, et al. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychol Med. 2014;44:117-26.
-
(2014)
Psychol Med.
, vol.44
, pp. 117-126
-
-
Clausen, L.1
Hjorthoj, C.R.2
Thorup, A.3
Jeppesen, P.4
Petersen, L.5
Bertelsen, M.6
-
23
-
-
84865998027
-
Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis
-
Faridi K, Joober R, Malla A. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis. Schizoph Res. 2012;141:78-82.
-
(2012)
Schizoph Res.
, vol.141
, pp. 78-82
-
-
Faridi, K.1
Joober, R.2
Malla, A.3
-
24
-
-
84860833892
-
Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study
-
van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizoph Res. 2012;137:50-7.
-
(2012)
Schizoph Res.
, vol.137
, pp. 50-57
-
-
Dijk, D.1
Koeter, M.W.2
Hijman, R.3
Kahn, R.S.4
Brink, W.5
-
25
-
-
84878954045
-
Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization
-
Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction. 2013;108:1259-69.
-
(2013)
Addiction.
, vol.108
, pp. 1259-1269
-
-
Bahorik, A.L.1
Newhill, C.E.2
Eack, S.M.3
-
26
-
-
84861796547
-
Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial
-
Faber G, Smid HG, Van Gool AR, Wunderink L, van den Bosch RJ, Wiersma D. Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. J Clin Psychiatry. 2012;73:632-38.
-
(2012)
J Clin Psychiatry.
, vol.73
, pp. 632-638
-
-
Faber, G.1
Smid, H.G.2
Gool, A.R.3
Wunderink, L.4
Bosch, R.J.5
Wiersma, D.6
-
27
-
-
84928882689
-
Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: A 30-month follow-up study
-
González-Blanch C, Gleeson JF, Koval P, Cotton SM, McGorry PD, Alvarez-Jimenez M. Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: A 30-month follow-up study. PLoS ONE. 2015;10(4):e0122404.
-
(2015)
PLoS ONE
, vol.10
, Issue.4
-
-
González-Blanch, C.1
Gleeson, J.F.2
Koval, P.3
Cotton, S.M.4
McGorry, P.D.5
Alvarez-Jimenez, M.6
-
28
-
-
22344447728
-
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis
-
Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand. 2005;112:141-48.
-
(2005)
Acta Psychiatr Scand.
, vol.112
, pp. 141-148
-
-
Lambert, M.1
Conus, P.2
Lubman, D.I.3
Wade, D.4
Yuen, H.5
Moritz, S.6
-
29
-
-
84979693615
-
Revisión de los tratamientos psicológicos en primeros episodios psicóticos
-
Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social Servicio de Evaluación de Tecnologías Sanitarias del País Vasco 2009. Report of the Basque Office for Health Technology Assessment. (OSTEBA) No. 2007/08.
-
Ruiz de Azúa García S, González-Pinto Arrillaga A, Vega Pérez P, Gutíerrez Fraile M, Asua Batarrita J. Revisión de los tratamientos psicológicos en primeros episodios psicóticos. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social Servicio de Evaluación de Tecnologías Sanitarias del País Vasco 2009. Report of the Basque Office for Health Technology Assessment. (OSTEBA) No. 2007/08.
-
-
-
Ruiz de Azúa García, S.1
González-Pinto Arrillaga, A.2
Vega Pérez, P.3
Gutíerrez Fraile, M.4
Asua Batarrita, J.5
-
30
-
-
84885046638
-
Cognitive behavioral therapy after first episodes psychosis
-
Lecardeur L. Cognitive behavioral therapy after first episodes psychosis. Encephale. 2013;39:115-20.
-
(2013)
Encephale.
, vol.39
, pp. 115-120
-
-
Lecardeur, L.1
-
31
-
-
79960774988
-
Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial
-
Bonsack C, Gibellini S, Favrod J, Montagrin Y, Besson J, Bovet P, et al. Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychother Psychosom. 2011;80:287-97.
-
(2011)
Psychother Psychosom.
, vol.80
, pp. 287-297
-
-
Bonsack, C.1
Gibellini, S.2
Favrod, J.3
Montagrin, Y.4
Besson, J.5
Bovet, P.6
-
32
-
-
33745818603
-
Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis
-
Edwards J, Elkins K, Hinton M, Harrigan SM, Donovan K, Athanasopoulos O, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand. 2006;114:109-17.
-
(2006)
Acta Psychiatr Scand.
, vol.114
, pp. 109-117
-
-
Edwards, J.1
Elkins, K.2
Hinton, M.3
Harrigan, S.M.4
Donovan, K.5
Athanasopoulos, O.6
-
33
-
-
84860586478
-
Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial
-
Hjorthøj CR, Fohlmann A, Larsen AM, Arendt M, Nordentoft M. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction. 2012a;107:1123-31.
-
(2012)
Addiction
, vol.107
, pp. 1123-1131
-
-
Hjorthøj, C.R.1
Fohlmann, A.2
Larsen, A.M.3
Arendt, M.4
Nordentoft, M.5
-
34
-
-
84871938589
-
A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness
-
Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, et al. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophr Res. 2013;143:138-42.
-
(2013)
Schizophr Res.
, vol.143
, pp. 138-142
-
-
Madigan, K.1
Brennan, D.2
Lawlor, E.3
Turner, N.4
Kinsella, A.5
O'Connor, J.J.6
-
35
-
-
84924283350
-
A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial
-
Barrowclough C, Marshall M, Gregg L, Fitzsimmons M, Tomenson B, Warburton J, et al. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychol Med. 2014;44:2749-61.
-
(2014)
Psychol Med.
, vol.44
, pp. 2749-2761
-
-
Barrowclough, C.1
Marshall, M.2
Gregg, L.3
Fitzsimmons, M.4
Tomenson, B.5
Warburton, J.6
-
36
-
-
84870469320
-
-
(text rev.). Washington, DC: American Psychiatric Association;
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., (text rev.). Washington, DC: American Psychiatric Association; 2000.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders, 4th ed.
-
-
-
37
-
-
0000262577
-
EUROP-ASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence
-
Kokkevi A, Hartgers C. EUROP-ASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 2015;1:208-10.
-
(2015)
Eur Addict Res.
, vol.1
, pp. 208-210
-
-
Kokkevi, A.1
Hartgers, C.2
-
38
-
-
4243429844
-
Índice europeo de la severidad de la adicción: EuropASI
-
Versión española, Actas de la IV Reunión Interregional de Psiquiatría
-
Bobes J, González MP, Sáiz PA, Bousoño M. Índice europeo de la severidad de la adicción: EuropASI. Versión española, Actas de la IV Reunión Interregional de Psiquiatría. 1996. p. 201-18.
-
(1996)
, pp. 201-218
-
-
Bobes, J.1
González, M.P.2
Sáiz, P.A.3
Bousoño, M.4
-
39
-
-
77949364471
-
The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults
-
Bashford J, Ross F, Copeland Jan. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction. 2010;105:615-25.
-
(2010)
Addiction
, vol.105
, pp. 615-625
-
-
Bashford, J.1
Ross, F.2
Jan, C.3
-
40
-
-
1942523532
-
Hungarian adaptation of the European Addiction Severity Index
-
Gerevich J, Bacskai E, Rozsa S. Hungarian adaptation of the European Addiction Severity Index. J Subst Use. 2004;9:185-91.
-
(2004)
J Subst Use.
, vol.9
, pp. 185-191
-
-
Gerevich, J.1
Bacskai, E.2
Rozsa, S.3
-
41
-
-
41949098135
-
The reliability and validity testing of the Hungarian version of the EuropASI
-
Jozsef R, Csilla P, Nauszika MA. The reliability and validity testing of the Hungarian version of the EuropASI. Magyar Psichologiai Szemle. 2002;57:587-603.
-
(2002)
Magyar Psichologiai Szemle.
, vol.57
, pp. 587-603
-
-
Jozsef, R.1
Csilla, P.2
Nauszika, M.A.3
-
42
-
-
1942523531
-
Introduction of the EuropASI in Norway: clinical and research experiences from a cost-effectiveness study
-
Lauritzen G, Ravndal E. Introduction of the EuropASI in Norway: clinical and research experiences from a cost-effectiveness study. J Subst Use. 2004;9:141-6. 11.
-
(2004)
J Subst Use
, vol.9
, pp. 141-146
-
-
Lauritzen, G.1
Ravndal, E.2
-
43
-
-
0033851847
-
Anwendung des European Addiction Severity Index (EuropASI) im Rahmen einer ambulanten Behandlung von Drogenabhängigen
-
Weiler D, Vogt M, Kufner H. Anwendung des European Addiction Severity Index (EuropASI) im Rahmen einer ambulanten Behandlung von Drogenabhängigen. Zeistchrift fur Wissenschaft und Praxis. 2000;46:197-208.
-
(2000)
Zeistchrift fur Wissenschaft und Praxis.
, vol.46
, pp. 197-208
-
-
Weiler, D.1
Vogt, M.2
Kufner, H.3
-
44
-
-
0033637119
-
Reliability and validity of the German version of the European Addiction Severity Index (EuropASI)
-
Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, et al. Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol. 2000;61:916-9.
-
(2000)
J Stud Alcohol.
, vol.61
, pp. 916-919
-
-
Scheurich, A.1
Muller, M.J.2
Wetzel, H.3
Anghelescu, I.4
Klawe, C.5
Ruppe, A.6
-
47
-
-
0027172920
-
Assessment of insight in psychosis
-
Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150:873-79.
-
(1993)
Am J Psychiatry.
, vol.150
, pp. 873-879
-
-
Amador, X.F.1
Strauss, D.H.2
Yale, S.A.3
Flaum, M.M.4
Endicott, J.5
Gorman, J.M.6
-
48
-
-
42549086390
-
Spanish adaptation of the Scale to Assess Unawareness of Mental Disorder (SUMD)
-
Ruiz A, Pousa E, Duñó R, Crosas J, Cuppa S, García C. Spanish adaptation of the Scale to Assess Unawareness of Mental Disorder (SUMD). Actas Esp Psiquiatr. 2008;36:1191-98.
-
(2008)
Actas Esp Psiquiatr.
, vol.36
, pp. 1191-1198
-
-
Ruiz, A.1
Pousa, E.2
Duñó, R.3
Crosas, J.4
Cuppa, S.5
García, C.6
-
49
-
-
0022632510
-
Concurrent and predictive validity of a self-reported measure of medication adherence
-
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
-
(1986)
Med Care.
, vol.24
, pp. 67-74
-
-
Morisky, D.E.1
Green, L.W.2
Levine, D.M.3
-
50
-
-
0026482157
-
Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test [in Spanish]
-
Val A, Amorós G, Martínez P, Fernández ML, León M. Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test [in Spanish]. Aten Primaria. 1992;10:767-70.
-
(1992)
Aten Primaria.
, vol.10
, pp. 767-770
-
-
Val, A.1
Amorós, G.2
Martínez, P.3
Fernández, M.L.4
León, M.5
-
51
-
-
0023606101
-
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
-
Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizoph Bull. 1987;13:261-76.
-
(1987)
Schizoph Bull.
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
52
-
-
0001230724
-
Validation of Positive and Negative Symptom Scale (PANSS) in a sample of Spanish schizophrenic patients
-
Peralta-Martin V, Cuesta-Zorita MJ. Validation of Positive and Negative Symptom Scale (PANSS) in a sample of Spanish schizophrenic patients. Actas Luso-Esp Neurol, Psiquiatr Cienc Afines. 1994;22:171-77.
-
(1994)
Actas Luso-Esp Neurol, Psiquiatr Cienc Afines.
, vol.22
, pp. 171-177
-
-
Peralta-Martin, V.1
Cuesta-Zorita, M.J.2
-
53
-
-
0014186152
-
Development of a rating scale for primary depressive illness
-
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-96.
-
(1967)
Br J Soc Clin Psychol.
, vol.6
, pp. 278-296
-
-
Hamilton, M.1
-
54
-
-
0022745925
-
Validación de la versión castellana de la escala de Hamilton para la depresión
-
Ramos-Brieva JCA. Validación de la versión castellana de la escala de Hamilton para la depresión. Actas Luso-Esp Neurol, Psiquiatr Cienc Afines. 1986;14:324-34.
-
(1986)
Actas Luso-Esp Neurol, Psiquiatr Cienc Afines.
, vol.14
, pp. 324-334
-
-
Ramos-Brieva, J.C.A.1
-
55
-
-
0018175277
-
A rating scale for mania: reliability, validity and sensitivity
-
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatr. 1978;1:429-35.
-
(1978)
Br J Psychiatr.
, vol.1
, pp. 429-435
-
-
Young, R.C.1
Biggs, J.T.2
Ziegler, V.E.3
Meyer, D.A.4
-
56
-
-
0037190284
-
Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young
-
Colom F, Vieta E, Martínez-Arán A, García-García M, Reinares M, Torrent C, Goikolea JM, Banús S, Salamero S. Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young. Med Clin (Barc). 2002;119:366-71.
-
(2002)
Med Clin (Barc)
, vol.119
, pp. 366-371
-
-
Colom, F.1
Vieta, E.2
Martínez-Arán, A.3
García-García, M.4
Reinares, M.5
Torrent, C.6
Goikolea, J.M.7
Banús, S.8
Salamero, S.9
-
57
-
-
51549099524
-
The assessment of anxiety states by rating
-
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.
-
(1959)
Br J Med Psychol.
, vol.32
, pp. 50-55
-
-
Hamilton, M.1
-
58
-
-
0037070878
-
Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad
-
Lobo A, Chamorro L. Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Med Clin (Barc). 2002;118:493-9.
-
(2002)
Med Clin (Barc)
, vol.118
, pp. 493-499
-
-
Lobo, A.1
Chamorro, L.2
-
59
-
-
34447316121
-
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
-
Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.
-
(2007)
Clin Pract Epidemiol Ment Health.
, vol.3
, pp. 5
-
-
Rosa, A.R.1
Sánchez-Moreno, J.2
Martínez-Aran, A.3
Salamero, M.4
Torrent, C.5
Reinares, M.6
Comes, M.7
Colom, F.8
Riel, W.9
Ayuso-Mateos, J.L.10
Kapczinski, F.11
Vieta, E.12
-
62
-
-
0002591676
-
Toward a comprehensive model of change
-
In: Miller WR, Heather N, editors. New York: Plenum Press;
-
Prochaska JO, DiClemente CC. Toward a comprehensive model of change. In: Miller WR, Heather N, editors. Addictive behaviors: processes of change. New York: Plenum Press; 1986. p. 3-28.
-
(1986)
Addictive behaviors: processes of change
, pp. 3-28
-
-
Prochaska, J.O.1
DiClemente, C.C.2
|